Page 2 - Robert Wasserman News Today

Benchmark analyst Robert Wasserman reiterated a Buy rating on AbCellera Biologics Inc. (NASDAQ: ABCL), 

Benchmark analyst Robert Wasserman reiterated a Buy rating on AbCellera Biologics Inc. ABCL, lowering the price target to $12 on reduced valuations for other…

New Bedford Police report, prepared over 18 months, recommends measures to modernize the department, and improve performance.

The New Bedford Police Department announced on Thursday the findings of a two-year comprehensive review of the department's policies and conduct.

Emergent BioSolutions Inc. (EBS) shares are gaining more than 10 percent on Monday morning after Analyst Robert Wasserman raised the rating from Hold to Buy with price target of $22.

The biotech plans to launch the over-the-counter product this summer, beating competitors to the punch.

The U.S. Food and Drug Administration on Wednesday approved over-the-counter (OTC) sales of Emergent BioSolutions Inc's Narcan, allowing for easier availability of the life-saving medication used to reverse opioid overdoses.

"For people who need it most, it needs to be at a lower price point than what it is currently available," said Maryann Mason, associate professor of emergency medicine at Northwestern University.

(Reuters) -The U.S. Food and Drug Administration on Wednesday approved using Emergent BioSolutions Inc's Narcan without a prescription, paving the way...

The U.S. Food and Drug Administration on Wednesday approved over-the-counter (OTC) sales of Emergent BioSolutions Incs Narcan, allowing for easier availability of the life-saving medication used to